Vomiting evaluation

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Now I have comprehensive content from multiple authoritative sources. Let me compile the full evaluation.

Vomiting — Clinical Evaluation

Definition & Physiology

Vomiting is the forceful expulsion of gastric contents through the mouth, coordinated by the vomiting center in the medullary reticular formation. It proceeds through three sequential phases:
  1. Nausea — increased duodenal/jejunal tone, decreased gastric tone → intestinal contents reflux into stomach; associated with hypersalivation and tachycardia
  2. Retching — rhythmic, synchronous contraction of diaphragm, abdominal muscles, and intercostal muscles against a closed glottis, without expulsion
  3. Vomiting — contraction of external oblique and rectus abdominis + relaxation of hiatal diaphragm → increased thoracoabdominal pressure; simultaneous relaxation of gastric fundus, cardia, and upper esophageal sphincter; glottis closes to prevent aspiration
Neural connections of the vomiting center, showing vagal and sympathetic afferents feeding the chemoreceptor trigger zone and vomiting center in the medulla
Figure: The vomiting center (medullary/pontine reticular formation) receives input from vagal and sympathetic afferents from the GI tract and from the chemoreceptor trigger zone (CTZ) in the area postrema. — Guyton & Hall Medical Physiology

Afferent Inputs to the Vomiting Center

SourceExamples
GI visceral afferents (vagal/sympathetic)Gastric distension, irritation, duodenal stimuli
Extra-GI visceral afferentsBiliary system, peritoneum, pharynx, genitalia, heart (e.g., MI)
CNS/cortical afferentsVestibular system, thalamus, cerebral cortex
Chemoreceptor trigger zone (CTZ)Area postrema, floor of 4th ventricle — partially outside the blood-brain barrier; responds to drugs (morphine, digoxin, apomorphine, chemotherapy), toxins, metabolic derangements
The CTZ is rich in dopamine D2 and serotonin (5-HT3) receptors; the lateral vestibular nucleus is rich in cholinergic and histamine receptors — these are targets for antiemetic therapy.

History

Characterize the Vomiting

FeatureClinical significance
Timing/onsetAcute (<1 week) vs. chronic (>1 month)
Relationship to mealsImmediately post-prandial → gastric outlet obstruction or pyloric stenosis; early morning → pregnancy, raised ICP, uremia
Frequency and volumeCopious/frequent → obstruction
Effortless/projectileProjectile without nausea → CNS etiology (raised ICP)
Relief with vomitingRelieves pain in PUD and bowel obstruction; no relief in inflammatory conditions (cholecystitis, pancreatitis)

Characteristics of the Vomitus

Vomitus AppearanceSuggested Diagnosis
Bright red bloodPeptic ulcer, gastritis, esophageal varices, Mallory-Weiss tear, Dieulafoy lesion, aortoenteric fistula
Coffee-groundAny upper GI bleed; Hgb → hematin via gastric acid; also iron tablets, red wine
Undigested foodGastric outlet obstruction, achalasia, esophageal stricture/atresia
Bilious (yellow-green)Obstruction distal to ampulla of Vater
Feculent (brown, fecal odor)Advanced low small bowel or large bowel obstruction
True fecesGastrocolic fistula

Associated Symptoms

  • Diarrhea + fever + myalgias → infectious gastroenteritis
  • Headache + visual changes + neck stiffness → CNS etiology (meningitis, raised ICP, intracranial mass)
  • Nystagmus + vertigo + tinnitus → vestibular/labyrinthine disease
  • Abdominal pain → obstruction, PUD, cholecystitis, pancreatitis, appendicitis
  • Chest pain → myocardial infarction (especially inferior MI), esophageal rupture
  • Dysphagia → esophageal disease
  • Jaundice → hepatobiliary disease
  • Episodic with hot-shower relief + cannabis use → cannabinoid hyperemesis syndrome (CHS)

Differential Diagnosis by Category

GI Causes

  • Gastroenteritis (most common, usually viral/self-limited)
  • Peptic ulcer disease / gastritis
  • Gastric outlet obstruction (pyloric stenosis, malignancy)
  • Intestinal obstruction (adhesions, hernia, volvulus, intussusception)
  • Acute cholecystitis, cholelithiasis
  • Acute pancreatitis
  • Hepatitis
  • Achalasia / esophageal stricture
  • Gastroparesis

Neurologic / CNS

  • Meningitis
  • Intracranial hypertension (tumor, hydrocephalus, hemorrhage)
  • Migraine
  • Labyrinthitis / vestibular neuritis / motion sickness
  • Post-concussion syndrome

Metabolic / Endocrine

  • Diabetic ketoacidosis
  • Renal failure (uremia)
  • Adrenal insufficiency
  • Hyperparathyroidism / hypercalcemia
  • Hypo/hyperthyroidism

Drugs & Toxins

  • Opioids (morphine, codeine)
  • Digoxin toxicity
  • Chemotherapy
  • NSAIDs
  • Alcohol

Obstetric

  • Pregnancy (hyperemesis gravidarum)

Cardiac

  • Inferior/posterior myocardial infarction

Other

  • Cyclical vomiting syndrome (CVS) — episodic, migraine-associated
  • Cannabinoid hyperemesis syndrome (CHS)
  • Psychogenic / bulimia nervosa
  • Post-operative nausea and vomiting (PONV)

Age-Based Consideration (Pediatric)

AgePriority Diagnoses
NewbornEsophageal/intestinal atresia, malrotation ± volvulus, Hirschsprung's, metabolic disorders, sepsis
Infant (<12 mo)Pyloric stenosis, intussusception, GERD, UTI, meningitis
Child (>12 mo)Gastroenteritis, intussusception, migraine, appendicitis, intracranial mass
Bilious or bloody vomitus, hematochezia, or significant abdominal pain should trigger concern for diagnoses beyond simple viral gastroenteritis. — Tintinalli's Emergency Medicine

Physical Examination

SystemFindingSuggested Diagnosis
GeneralPoor skin turgor, dry mucous membranesDehydration
Vital signsFeverGastroenteritis, cholecystitis, appendicitis, peritonitis
Vital signsTachycardia + orthostatic changesDehydration/volume depletion
EyesNystagmusLabyrinthitis, vertebrobasilar insufficiency, cerebellar infarct/bleed, drug intoxication
EyesPapilledemaRaised ICP (CNS tumor, bleed)
NeckGoiterThyroid disease
LungsRalesPneumonia
AbdomenDistension, high-pitched bowel soundsObstruction
AbdomenRUQ tenderness + Murphy's signCholecystitis
AbdomenRigidity/guardingPeritonitis, perforation
OralLoss of dental enamelBulimia nervosa

Complications of Vomiting

  • Metabolic alkalosis with hypochloremia and hypokalemia (from loss of H⁺ and Cl⁻)
  • Dehydration and electrolyte disturbances
  • Mallory-Weiss tear — mucosal laceration at gastroesophageal junction from violent retching
  • Boerhaave syndrome — full-thickness esophageal rupture → mediastinitis/peritonitis (life-threatening)
  • Aspiration pneumonitis — in patients with impaired consciousness
  • Malnutrition / weight loss
  • Wernicke encephalopathy — in prolonged vomiting (thiamine depletion)
  • Bezoar formation in severe gastroparesis

Diagnostic Workup

Guided by history and physical; no single test is universally indicated.
TestIndication
BMP/electrolytes, BUN, CrAssess dehydration, metabolic alkalosis, renal failure
CBCInfection, anemia
LFTs, lipaseBiliary/pancreatic disease
Urine hCGAny woman of reproductive age
UrinalysisUTI, renal disease
Blood glucoseDKA
Upright CXR / AXRFree air (perforation), obstruction (air-fluid levels), pneumonia
CT abdomen/pelvisObstruction, appendicitis, pancreatitis, mass
Head CT / MRISuspected CNS etiology
Upper endoscopyChronic vomiting, hematemesis, suspected mucosal disease
Gastric emptying scanSuspected gastroparesis

Management

Immediate Priorities

  1. Assess and protect the airway (especially in altered consciousness)
  2. Assess hemodynamic status and volume depletion → IV crystalloid if severe
  3. Hold oral medications; find parenteral substitutes as needed
  4. Consider nasogastric tube if obstruction or high-output vomiting

Antiemetics

DrugClassMechanismDoseNotes
Ondansetron5-HT3 antagonistCTZ + vagal GI terminals4–8 mg IV/POFirst-line; generally well-tolerated
MetoclopramideD2/5-HT2 antagonistCTZ + gastric motility10–20 mg IM/IV q6hRisk of tardive dyskinesia (black box)
ProchlorperazineD1/D2 antagonistCTZ5–10 mg IM/PO; 25 mg PRExtrapyramidal effects
Droperidol / HaloperidolD2 antagonistCTZ1.25 / 5 mg IVQT prolongation monitoring
PromethazineH1/muscarinic antagonistVestibular nucleus12.5–25 mg IM/IVSedating; IV route → tissue necrosis risk
DimenhydrinateH1 antagonistVestibular nucleus25–50 mg PO/IVMotion sickness
DexamethasoneCorticosteroidCNS/undefined4–8 mg IVPONV, chemotherapy-induced
AprepitantNK1 antagonistSubstance P/CTZ40–125 mg POPONV, chemotherapy
ScopolamineMuscarinic antagonistVestibular nucleus1.5 mg patchMotion sickness
ED stepwise approach (Rosen's Emergency Medicine):
  1. Ondansetron 4 mg IV → repeat after 15–30 min if needed
  2. Add metoclopramide 10 mg IV if inadequate
  3. Consider droperidol 1.25 mg IV or haloperidol 5 mg IV (if mechanical obstruction excluded)
  4. Prochlorperazine 10 mg IV or promethazine 12.5 mg IM/IV if above fail

Special Situations

  • Cannabinoid hyperemesis syndrome: cessation of cannabis (definitive); acute — capsaicin cream topically, haloperidol, or lorazepam; hot showers provide temporary relief
  • Post-operative vomiting: aprepitant, ondansetron, dexamethasone, droperidol (combination additive); rule out anastomotic leak, ileus
  • Pregnancy (hyperemesis gravidarum): pyridoxine (B6) ± doxylamine first-line; ondansetron second-line; IV fluids, thiamine supplementation

Sources: Tintinalli's Emergency Medicine; Rosen's Emergency Medicine; Guyton & Hall Textbook of Medical Physiology; Yamada's Textbook of Gastroenterology; S. Das Manual on Clinical Surgery; Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.